Tagged Articles

obese 26 articles

Testosterone therapy does not appear to work in obese men with type 2 diabetes

Testosterone replacement therapy is designed to treat symptoms of “Low T,” such as low libido, weight gain, and fatigue; however, the treatment doesn’t appear to work on aging, obese men with type 2 diabetes, a new study shows. The new study published in The Journal of Clinical Endocrinology & Metabolism, found that testosterone supplements do not improve erectile dysfunction or general health in this population because testosterone levels are not the only issue causing their symptoms. The findings raise even more question about the controversial hormone supplements. Prescriptions for testosterone therapies, such as the widely used Androgel, Axiron and Testim, have skyrocketed ... Read More

Rise in obesity rates puts more people at risk of serious health consequences

An estimated one-third of the world’s adult population is overweight or obese and at risk of developing diabetes and other serious health conditions, according to a new study by the Overseas Development Institute (ODI). “The evidence is well established: obesity, together with excessive consumption of fat and salt, is linked to the rising global incidence of non-communicable diseases including some cancers, diabetes, heart disease, and strokes,” the report states. The study found the biggest problem to be in developing countries, where an estimated 900 million are considered overweight – nearly three times as many as 1980. Comparatively, about 550 million ... Read More

Lifestyle intervention does not reduce risk of heart attacks, strokes in type 2 diabetics

A controlled diet and exercise plan may help patients with type 2 diabetes lose weight, but the weight loss did not reduce their risk for having heart problems, a new study shows. The study, sponsored by the National Institutes of Health (NIH), looked at the long-term effects of healthy nutrition and exercise in overweight people with type 2 diabetes. More than 5,000 obese adults ages 45 to 76 with type 2 diabetes were followed for nearly 10 years. Half of the participants focused on lifestyle intervention through physical activity and low calorie intake, and the other half was given conventional ... Read More

Could marijuana be the next diabetes treatment?

Sure, marijuana use has been tied to “the munchies,” which would make one assume the “muncher” would be more apt to be plump, thus at higher risk of being diabetic. But tokers are far less likely to be obese or have diabetes, previous studies have found. A new study suggests that cannabis compounds may actually help control blood sugar. “The most important finding is that current users of marijuana appear to have better carbohydrate metabolism than nonusers,” Murray Mittleman, an associate professor of medicine at the Harvard School of Medicine, told CNN. “Their fasting insulin levels were lower, and they ... Read More

Novo Nordisk testing higher doses of Victoza as weight loss drug for obese diabetics

Novo Nordisk is hoping data from a phase III trial involving a higher dosage of its type 2 diabetes drug Victoza (liraglutide) will show it can help overweight and obese people with the chronic disease lose weight. The first of three studies in the pharmaceutical company’s SCALE clinical program showed promising results. Patients given a high (3mg) dose achieved a 6 percent reduction in weight compared to a 2 percent reduction in patients taking a placebo. Victoza is already approved in 1.8 mg dosage, and previous studies have shown the drug can reduce weight in patients by 5 percent. The ... Read More

Advocates push for more aggressive approach to gestational diabetes

A change in the way pregnant women are tested for gestation diabetes could greatly increase the number of women diagnosed with the disease, which may help keep both mother and baby healthier in the future. Gestational diabetes is a form of the disease that either starts or is first diagnosed during pregnancy. It is a growing problem, as more women are waiting until their 30s or 40s to have babies, and more women are overweight before they become pregnant. It is one of the most common complications of pregnancy. Almost all pregnant women are checked for gestational diabetes because if ... Read More

European drug advisors reject Qsiva (Qsymia) diet drug based on safety concerns

Advisors for the European Union’s health agency has again recommended against approving the new weight loss drug Qsiva, made by Vivus Inc. The Committee for Medicinal Products for Human Use raised concerns about the cardiovascular safety of the drug, saying it would need more data proving its safety before it would reconsider its rejection. Qsiva is a combination of two FDA-approved drugs – phentermine, an appetite suppressant, and topiramate, used to treat epilepsy and migraines. Phentermine was part of the fen-phen diet drug cocktail that was popular in the 1990s, but was pulled from the market after studies showed the ... Read More

European regulators skeptical about new prescription diet pills

European drug regulators are leery about approving the new weight loss drug Belviq because of safety concerns, including heart valve problems and psychiatric side effects in patients, and tumors observed during studies on lab rats. Belviq is currently under review by an advisory panel for the European Medicines Agency (EMA), which is expected to make a recommendation for the EMA by March whether to approve the drug. Arena Pharmaceuticals, the drug’s maker, has been working with the agency to answer questions and clear up any matters that stand in the way of approval. But its chances may be slim. The ... Read More

Diet pill Qsymia sales sluggish but analysts say pill has blockbuster potential

About 14,500 people have filled prescriptions for the new diet pill Qsymia since it hit the market in September, and the number of prescriptions are growing each month. Qsymia became the first weight loss pill to be sold in the U.S. since 1999. It is intended to be a lifelong treatment to help overweight and obese people manage their weight. Qysmia is a combination phentermine, a stimulant that acts as an appetite suppressant, and topiramate, a drug used to treat seizures. Analysts speculate that it could become blockbuster drug within a few years, generating sales of $1 billion or more. ... Read More

‘Lifestyle intervention’ for weight loss does not improve heart attack risk in diabetics

Longtime type 2 diabetics who undergo “lifestyle intervention” and lose weight do not reduce their heart attack and stroke risk, suggests a new study supported by the National Institutes of Health. The study focused on whether an intensive diet and exercise program resulting in weight loss would reduce the rates of heart disease, stroke, and cardiovascular-related deaths in overweight and obese people with type 2 diabetes. This demographic is already at greater risk for these conditions. For the study, researchers worked with more than 5,000 people. Half of the participants engaged in an intensive diet and exercise program while the ... Read More